Sage Journals: Discover world-class research

Open access

Research article

First published 2016

Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis

Michael D Ludwig, Anthony P Turel, Ian S Zagon [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-9

Featured Article: Serum [Met 5 ]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Michael D Ludwig, Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2008-9

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

M Gironi, F Martinelli-Boneschi, P Sacerdote [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2011-6

Enhancing Acupuncture by Low Dose Naltrexone

Jan M Keppel Hesselink, David J Kopsky

Acupuncture in Medicine

Retricted access

Other

First published 2010-8

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial

Naser Sharafaddinzadeh, Ali Moghtaderi, Davood Kashipazha [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2009-12

Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases

Burton M. Berkson, Daniel M. Rubin, Arthur J. Berkson

Integrative Cancer Therapies

Open access

Research article

First published 2010-1

Ultra-Low Dose Naltrexone Attenuates Chronic Morphine-Induced Gliosis in Rats

Theresa-Alexandra M Mattioli, Brian Milne, Catherine M Cahill

Molecular Pain

Open access

Review article

First published 2010

Ultra-Low-Dose Naloxone or Naltrexone to Improve Opioid Analgesia: The History,the Mystery and a Novel Approach

Lindsay H. Burns, Hoau-Yan Wang

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 2011-7

Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin

Renee N Donahue, Patricia J McLaughlin, Ian S Zagon

Experimental Biology and Medicine

Open access

Case report

First published 2020

Improvement in Hailey–Hailey disease with a combination of low-dose naltrexone and oral magnesium chloride: A case report

Darosa Lim, Annie Belisle, Sandra Davar

Sage Open Medical Case Reports

Search results